Annual Accounts Payable
$9.32 M
-$1.13 M-10.79%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual accounts payable is $9.32 million, with the most recent change of -$1.13 million (-10.79%) on December 31, 2023.
- During the last 3 years, DNA annual accounts payable has fallen by -$4.57 million (-32.89%).
- DNA annual accounts payable is now -32.89% below its all-time high of $13.89 million, reached on December 31, 2020.
Performance
DNA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$15.70 M
-$7.33 M-31.83%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly accounts payable is $15.70 million, with the most recent change of -$7.33 million (-31.83%) on September 30, 2024.
- Over the past year, DNA quarterly accounts payable has increased by +$6.38 million (+68.40%).
- DNA quarterly accounts payable is now -55.47% below its all-time high of $35.26 million, reached on March 31, 2022.
Performance
DNA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DNA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.8% | +68.4% |
| 3 y3 years | -32.9% | +68.4% |
| 5 y5 years | - | - |
DNA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.8% | +13.8% | -55.5% | +91.7% |
| 5 y | 5-year | -32.9% | +13.8% | -55.5% | +121.1% |
| alltime | all time | -32.9% | +13.8% | -55.5% | +121.1% |
Ginkgo Bioworks Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.70 M(-31.8%) |
| Jun 2024 | - | $23.03 M(-14.7%) |
| Mar 2024 | - | $27.00 M(+189.6%) |
| Dec 2023 | $9.32 M(-10.8%) | $9.32 M(-13.3%) |
| Sep 2023 | - | $10.75 M(-21.1%) |
| Jun 2023 | - | $13.63 M(-36.8%) |
| Mar 2023 | - | $21.57 M(+106.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $10.45 M(+27.6%) | $10.45 M(-7.7%) |
| Sep 2022 | - | $11.32 M(-41.8%) |
| Jun 2022 | - | $19.46 M(-44.8%) |
| Mar 2022 | - | $35.26 M(+330.5%) |
| Dec 2021 | $8.19 M(-41.1%) | $8.19 M(+15.3%) |
| Sep 2021 | - | $7.10 M(-48.9%) |
| Dec 2020 | $13.89 M | $13.89 M |
FAQ
- What is Ginkgo Bioworks Holdings annual accounts payable?
- What is the all time high annual accounts payable for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual accounts payable year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly accounts payable year-on-year change?
What is Ginkgo Bioworks Holdings annual accounts payable?
The current annual accounts payable of DNA is $9.32 M
What is the all time high annual accounts payable for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual accounts payable is $13.89 M
What is Ginkgo Bioworks Holdings annual accounts payable year-on-year change?
Over the past year, DNA annual accounts payable has changed by -$1.13 M (-10.79%)
What is Ginkgo Bioworks Holdings quarterly accounts payable?
The current quarterly accounts payable of DNA is $15.70 M
What is the all time high quarterly accounts payable for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly accounts payable is $35.26 M
What is Ginkgo Bioworks Holdings quarterly accounts payable year-on-year change?
Over the past year, DNA quarterly accounts payable has changed by +$6.38 M (+68.40%)